T cell senescence and CAR-T cell exhaustion in hematological malignancies

D Kasakovski, L Xu, Y Li - Journal of hematology & oncology, 2018 - Springer
T cell senescence has been recognized to play an immunosuppressive role in the aging
population and cancer patients. Strategies dedicated to preventing or reversing replicative …

T-cells in chronic lymphocytic leukemia: guardians or drivers of disease?

PM Roessner, M Seiffert - Leukemia, 2020 - nature.com
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, which is associated with
profound alterations and defects in the immune system and a prevalent dependency on the …

Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia

V Griggio, F Perutelli, C Salvetti, E Boccellato… - Frontiers in …, 2020 - frontiersin.org
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by a wide range of
tumor-induced alterations, which affect both the innate and adaptive arms of the immune …

Emerging canonical and non-canonical roles of granzyme B in health and disease

E Tibbs, X Cao - Cancers, 2022 - mdpi.com
Simple Summary Granzyme B (GzmB) is a potent cytotoxic molecule that is used by cytotoxic
T lymphocytes and natural killer cells to kill targeted infected or cancerous cells. Since its …

EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia

PM Roessner, L Llaó Cid, E Lupar, T Roider, M Bordas… - Leukemia, 2021 - nature.com
The transcription factor eomesodermin (EOMES) promotes interleukin (IL)-10 expression in
CD4+ T cells, which has been linked to immunosuppressive and cytotoxic activities. We …

Follicular B lymphomas generate regulatory T cells via the ICOS/ICOSL pathway and are susceptible to treatment by anti-ICOS/ICOSL therapy

KS Le, ML Thibult, S Just-Landi, S Pastor… - Cancer research, 2016 - AACR
The prognosis of follicular lymphoma (FL) patients is suspected to be influenced by tumor-
infiltrating regulatory T cells (Treg). The mechanism of Treg enrichment in FL and their …

Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate

W Wang, P Hodkinson, F McLaren… - … Journal of Cancer, 2012 - Wiley Online Library
Small cell lung cancer (SCLC) kills at least one person every 2 hr in the United Kingdom.
Some patients do relatively well but most have rapidly progressive disease. There is no …

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies

K Maharaj, A Uriepero, E Sahakian… - Frontiers in …, 2022 - frontiersin.org
Regulatory T cells (Tregs) are responsible for maintaining immune homeostasis by
controlling immune responses. They can be characterized by concomitant expression of …

CAR T-cell therapy: the role of physical barriers and immunosuppression in lymphoma

G Enblad, H Karlsson, ASI Loskog - Human gene therapy, 2015 - liebertpub.com
Chimeric antigen receptor (CAR) T-cells have shown remarkable results in patients with B-
cell leukemia and lymphoma. However, while CAR T-cells have shown complete responses …

[HTML][HTML] Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia

H Wu, P Li, N Shao, J Ma, M Ji, X Sun… - Oncology …, 2012 - spandidos-publications.com
Acute myeloid leukemia (AML) is the most common hematological malignancy in adults,
characterized by distorted proliferation and the development of myeloid cells and their …